AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
117 hedge funds and large institutions have $552M invested in Accelerate Diagnostics in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 35 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less capital invested
Capital invested by funds: $589M → $552M (-$37.5M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
117
Holding in Top 10
3
Calls
$23.5M
Puts
$14M
Top Buyers
| 1 | +$5.57M | |
| 2 | +$5.37M | |
| 3 | +$4.11M | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$3.22M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$1.79M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$10.1M | |
| 3 | -$8.89M | |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$4.98M |
| 5 |
MGM
Miura Global Management
New York
|
-$4.57M |